- Home
- FNGR vs ABEO Comparison
FNGR vs ABEO Comparison
Compare FNGR & ABEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FNGR
- ABEO
- Stock Information
- Founded
- FNGR 2016
- ABEO N/A
- Country
- FNGR Singapore
- ABEO United States
- Employees
- FNGR N/A
- ABEO N/A
- Industry
- FNGR Computer Software: Prepackaged Software
- ABEO Biotechnology: Pharmaceutical Preparations
- Sector
- FNGR Technology
- ABEO Health Care
- Exchange
- FNGR Nasdaq
- ABEO Nasdaq
- Market Cap
- FNGR 108.1M
- ABEO 277.6M
- IPO Year
- FNGR N/A
- ABEO 1980
- Fundamental
- Price
- FNGR $2.04
- ABEO $6.74
- Analyst Decision
- FNGR
- ABEO Strong Buy
- Analyst Count
- FNGR 0
- ABEO 3
- Target Price
- FNGR N/A
- ABEO $18.00
- AVG Volume (30 Days)
- FNGR 156.1K
- ABEO 270.0K
- Earning Date
- FNGR 10-15-2024
- ABEO 11-11-2024
- Dividend Yield
- FNGR N/A
- ABEO N/A
- EPS Growth
- FNGR N/A
- ABEO N/A
- EPS
- FNGR N/A
- ABEO N/A
- Revenue
- FNGR $31,176,174.00
- ABEO N/A
- Revenue This Year
- FNGR $260.03
- ABEO N/A
- Revenue Next Year
- FNGR N/A
- ABEO $7,097.06
- P/E Ratio
- FNGR N/A
- ABEO N/A
- Revenue Growth
- FNGR N/A
- ABEO 147.52
- 52 Week Low
- FNGR $1.63
- ABEO $3.05
- 52 Week High
- FNGR $7.25
- ABEO $9.01
- Technical
- Relative Strength Index (RSI)
- FNGR 44.32
- ABEO 66.23
- Support Level
- FNGR $2.06
- ABEO $6.15
- Resistance Level
- FNGR $2.46
- ABEO $6.74
- Average True Range (ATR)
- FNGR 0.13
- ABEO 0.32
- MACD
- FNGR -0.01
- ABEO -0.00
- Stochastic Oscillator
- FNGR 6.67
- ABEO 95.51
About FNGR FingerMotion Inc.
FingerMotion Inc is engaged in the provision of mobile payment and recharge services in the Chinese market. The company business line includes Telecommunications Products and Services; Value Added Products and Services; Short Message Services (SMS) and Multimedia Messaging Services (MMS); a Rich Communication Services (RCS) platform; Big Data Insights; and a Video Games Division (inactive). It principally earns revenue by providing mobile payment and recharge services to customers of telecommunications companies in China.
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel AIM.